| Michael Ramos, MD | |
|
3811 W Gore Blvd, Suite 1, Lawton, OK 73505 | |
| (580) 585-5550 | |
| (580) 585-5551 |
| Full Name | Michael Ramos |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 3811 W Gore Blvd, Lawton, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063407781 | NPI | - | NPPES |
| 5519282 | Other | OK | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 16850 (Oklahoma) | Primary |
| Entity Name | Comanche County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588832869 PECOS PAC ID: 2668373689 Enrollment ID: O20140602001702 |
News Archive
A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
The Employer and Broker Solutions Group of A.D.A.M., Inc., which provides client acquisition, retention, and agency management solutions to nearly 600 of the nation's top health benefits brokers, today announced that it has launched Advisor Tools 2.0, A.D.A.M.'s comprehensive suite of applications for brokers that includes proprietary benchmark reporting, research and regulatory information, and other valuable HR tools.
A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Ramos, MD Po Box 785, Lawton, OK 73502 Ph: (580) 357-9984 | Michael Ramos, MD 3811 W Gore Blvd, Suite 1, Lawton, OK 73505 Ph: (580) 585-5550 |
News Archive
A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
The Employer and Broker Solutions Group of A.D.A.M., Inc., which provides client acquisition, retention, and agency management solutions to nearly 600 of the nation's top health benefits brokers, today announced that it has launched Advisor Tools 2.0, A.D.A.M.'s comprehensive suite of applications for brokers that includes proprietary benchmark reporting, research and regulatory information, and other valuable HR tools.
A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.
› Verified 2 days ago
Mark W Cotton, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5610 Sw Lee Blvd, Lawton, OK 73505 Phone: 580-536-6600 Fax: 580-536-2427 | |
John C Loose, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3201 W Gore Blvd Ste 305, Memorial Medical Group, Lawton, OK 73505 Phone: 580-510-7070 | |
Dr. Ama Amofah, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-355-8699 | |
Joseph Dawley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 Nw Arlington Ave, Lawton, OK 73507 Phone: 580-248-2288 | |
Dr. Patrice Elaine Mooney, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 501 Se Flower Mound Rd, Lawton, OK 73501 Phone: 580-351-6511 | |
Dr. Gregory P Pineau, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Sw Goodyear Blvd, Lawton, OK 73505 Phone: 580-531-5878 Fax: 580-531-5779 |